Skip to content

Patient-centered Mobile Health Intervention to Improve Self-care in Patients With Chronic Heart Failure

iCardia4HF: A Patient-centered Mobile Health Intervention to Promote Self-care and Improve Patient Outcomes in Chronic Heart Failure

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03642275
Acronym
iCardia4HF
Enrollment
27
Registered
2018-08-22
Start date
2019-01-21
Completion date
2021-02-15
Last updated
2021-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

heart failure, mHealth, smartphone, wearable electronic devices, text messaging, self-management, self-care

Brief summary

Approximately 6.5 million people have heart failure (HF) in the United States, and 960,000 new cases are reported each year. HF is one of the most common hospital diagnosis among older adults. About 40% of patients are readmitted within 1-year following their first admission for HF and hospitalization accounts for approximately 80% of the costs of HF management. This pilot study aims to assess the feasibility, acceptability, and preliminary efficacy of a patient-centered mobile health (mHealth) technology intervention in older adults with chronic heart failure.

Detailed description

This is a single site, two-arm, pilot randomized controlled trial that aims to examine the feasibility, acceptability and preliminary efficacy of a mobile phone-based intervention compared to usual care in older adult patients with HF (≥50 years). Forty (n=40) patients from the University of Illinois Hospital & Health Sciences system will be enrolled in the study, randomly assigned to the intervention or usual care group, and followed for 60 days. Patients in the intervention group will receive the Heart Failure Health Storylines mobile app developed by Self Care Catalysts in collaboration with the Heart Failure Society of America, three connected health devices from Fitbit and Nokia that interface with the mobile app, and tailored text-messages targeting health beliefs, self-care efficacy, and knowledge about HF. The control group will receive standard care which involves patient education and outpatient follow up with physical and laboratory examinations as needed. The primary study outcome is change in self-care and quality of life. Secondary outcomes include hospital re-admissions and emergency room visits.

Interventions

BEHAVIORALiCardia4HF

Participants in the intervention group will receive the Heart Failure Health Storylines mobile app, three connected health devices that interface with the app (Fitbit Charge 2 activity tracker, and FDA-approved Nokia BP monitor and Cardio Body weight scale), and a program of tailored self-care text-messages, in addition to usual care. Participants will be asked to use the app and devices to record and self-monitor their daily symptoms, blood pressure, weight, and physical activity.

Sponsors

University of Illinois at Chicago
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Outcome assessors will be blinded to patients' randomization assignment

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Inpatients or outpatients with a diagnosis of HF as defined by the International Classification of Diseases (ICD-10) codes * Stage C, NYHA I, II or III * ≥ 40 years of age * Own a smartphone with text-messaging and internet plan * Ability to speak and read English * Live within 30 miles from UI Health

Exclusion criteria

* On an active waiting list for implanted ventricular assist device or heart transplant * Advanced renal disease (dialysis or creatinine \>4.0mg/dL) * End-stage HF (hospice candidate) * Active cancer * Individuals who are not their own primary caregiver * Discharge to a setting other than home * Patients with baseline Montreal Cognitive Assessment (MoCA) score of \< 22

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline in Self-care at 30 and 60 daysBaseline, 30 and 60 daysSelf-care will be measured with the Self-Care Heart Failure Index (SCHFI) v.6.2,87 which includes 3 subscales: self-care maintenance (10-items), self-care confidence (6-items), and self-care management (6-items). Standardized scores in each scale range from 0 to 100. A total score of ≥70 indicates adequate self-care.
Change from Baseline in Health-related Quality of Life (HRQoL) at 30 and 60 daysBaseline, 30 and 60 daysHRQoL will be measured with the Kansas City Cardiomyopathy Questionnaire (23-items) that quantifies physical function, symptoms (frequency, severity and recent change), social function, self-efficacy and knowledge, and quality of life. Lower scores indicate worse HRQoL.

Secondary

MeasureTime frameDescription
Hospitalizations60 daysThe number of hospitalizations during the study will be measured with both self-report and the electronic medical record.
ER visits60 daysThe number of emergency room visits will be collected based on both self-reports and the electronic medical record

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026